The difference of dCSMS between active treatment and placebo was highly significant but so small that the needed number of participants is believed to be increased multiple times to reflect a significant difference in comparison of QoL.The mean total SNOT-22 score was moderate in both groups according to the grading system proposed by Toma and colleagues and did not differ significantly in neither of the groups 14 .
← all excerpts
Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis.
1
—
—